PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-6.63%
Negative revenue growth while AVGO stands at 25.30%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-7.29%
Negative gross profit growth while AVGO is at 100.51%. Joel Greenblatt would examine cost competitiveness or demand decline.
-5.86%
Negative EBIT growth while AVGO is at 285.80%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-6.38%
Negative operating income growth while AVGO is at 285.80%. Joel Greenblatt would press for urgent turnaround measures.
-0.12%
Negative net income growth while AVGO stands at 182.32%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1.26%
Share reduction while AVGO is at 1.60%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-1.02%
Reduced diluted shares while AVGO is at 7.94%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
13.02%
Dividend growth 1.25-1.5x AVGO's 9.21%. Bruce Berkowitz would see if management’s capital return strategy is more aggressive yet sustainable.
-8.03%
Negative OCF growth while AVGO is at 21.34%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-10.39%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
70.78%
10Y revenue/share CAGR under 50% of AVGO's 199.69%. Michael Burry would suspect a lasting competitive disadvantage.
29.09%
5Y revenue/share CAGR under 50% of AVGO's 245.17%. Michael Burry would suspect a significant competitive gap or product weakness.
3.75%
3Y revenue/share CAGR under 50% of AVGO's 146.17%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
60.55%
10Y OCF/share CAGR under 50% of AVGO's 181.58%. Michael Burry would worry about a persistent underperformance in cash creation.
50.79%
Below 50% of AVGO's 669.57%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
42.19%
3Y OCF/share CAGR under 50% of AVGO's 88.46%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
177.33%
Below 50% of AVGO's 531.89%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
49.47%
Below 50% of AVGO's 697.30%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
200.49%
Positive short-term CAGR while AVGO is negative. John Neff would see a clear advantage in near-term profit trajectory.
31.01%
Below 50% of AVGO's 250.29%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
26.82%
Below 50% of AVGO's 189.73%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
2.97%
Below 50% of AVGO's 55.94%. Michael Burry suspects a serious short-term disadvantage in building book value.
1232.73%
Dividend/share CAGR of 1232.73% while AVGO is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
183.53%
Dividend/share CAGR of 183.53% while AVGO is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
100.21%
3Y dividend/share CAGR at 50-75% of AVGO's 189.37%. Martin Whitman might see a weaker short-term approach to distributing cash.
-15.64%
Firm’s AR is declining while AVGO shows 32.54%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
1.88%
Inventory shrinking or stable vs. AVGO's 7.68%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
-0.99%
Negative asset growth while AVGO invests at 1.83%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
0.49%
Under 50% of AVGO's 3.03%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-0.06%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-6.33%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-7.34%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.